IVF
INVO Fertility, Inc.NASDAQHealthcare$2.06-0.96%ClosedMarket Cap: $2.9M
As of 2026-04-09
Valuation
P/E (TTM)
—
PEG
—
P/B
0.50
P/S
0.41
EV/EBITDA
-0.28
DCF Value
$-10,482.34
FCF Yield
-270.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
39.2%
Operating Margin
-370.2%
Net Margin
-417.0%
ROE
-471.5%
ROA
-153.8%
ROIC
-235.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $1.8M | 35.8% | $-1.6M | $-2.6M | $-1.87 | — |
| Q2 2025 | $1.9M | 41.3% | $-3.0M | $-5.3M | $-22.88 | — |
| Q1 2025 | $1.6M | 36.2% | $-17.1M | $-17.4M | $-91.13 | — |
| Q4 2024 | $1.7M | 43.2% | $-4.0M | $-3.6M | $-65.75 | — |
| FY 2024 | $6.5M | 44.0% | $-8.1M | $-9.1M | $-219.56 | — |
| Q3 2024 | $1.4M | 31.0% | $-1.3M | $-1.6M | $-36.63 | — |
| Q2 2024 | $1.8M | 53.1% | $-1.9M | $-2.2M | $-2.25 | — |
| Q1 2024 | $1.6M | 46.1% | $-946.4K | $-1.6M | $-2.29 | — |
| Q4 2023 | $1.4M | 35.8% | $-1.5M | $-2.0M | $0.00 | — |
| FY 2023 | $3.0M | 36.0% | $-6.8M | $-8.0M | $-489.96 | — |
| Q3 2023 | $974.9K | 40.4% | $-886.3K | $-1.2M | $-0.21 | — |
| Q2 2023 | $315.9K | 19.1% | $-2.1M | $-2.2M | $-0.93 | — |